Viewing Study NCT02311569

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:13 PM
Ignite Modification Date: 2026-02-20 @ 8:09 PM
Study NCT ID: NCT02311569
Status: COMPLETED
Last Update Posted: 2019-05-15
First Post: 2014-12-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation
Sponsor: Swiss Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myeloproliferative Neoplasm View
None Primary Myelofibrosis View
None Essential Thrombocythemia View
None Polycythemia Vera View
Keywords:

Keywords

Keyword Brief Keyword Text View
None JAK2 View
None Mirabegron View
None Primary myelofibrosis View
None beta-3-mimetic drugs View
None Myeloproliferative neoplasm View
None Essential thrombocythemia View
None Polycythemia vera View
None Betmiga View
None JAK2-V617F View